Stryker stock holds near $327 as earnings and guidance stay in focus
Published on 08/25/2026 at 22:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Stryker Corp. (US8636671013) traded at $327.80 on August 25, 2026, after a 0.5% decline in the latest session, while the stock also sat well below its 52-week high of $396.86. The move comes against a backdrop of fiscal 2026 EPS guidance of $14.95 to $15.10 and a consensus price target of $386.28.
Latest numbers
The most recent quarter showed $6.59 billion in revenue and $3.69 in EPS, with revenue up 9.4% year over year and EPS ahead of the $3.49 estimate by $0.20. That combination matters because the market is still valuing the shares at a level that is lower than the average target implied by recent coverage.
Institutional ownership stands at 77.09%, and one recent filing-based update said The Manufacturers Life Insurance Company acquired 859,544 shares valued at $270.6 million. Another filing-based item pointed to 300,000 shares sold by a director for $100.8 million, keeping trading behavior and ownership shifts in the conversation.
Guidance and positioning
Fiscal 2026 EPS guidance of $14.95 to $15.10 gives investors a clear range to compare with the $3.69 quarterly result, while the stock's 50-day simple moving average of $327.39 and 200-day simple moving average of $332.16 show a tight technical zone. The gap between the current quote and the 52-week high of $396.86 is still large enough to matter for valuation-minded traders.
The stock also carries a dividend of $0.88 a quarter, or $3.52 annualized, with a yield of 1.1%. In a market that has recently focused on ownership changes and earnings delivery, that payout adds another dated number to the Stryker case.
Products and business
Stryker's portfolio spans hospital equipment, surgical systems, and orthopedic tools, which keeps the company tied to procedure volumes and capital spending in healthcare settings. That breadth helps explain why quarterly revenue growth and guidance updates still move the shares more than any single product line.
Price level
At $327.80 as of August 25, 2026, Stryker stock remained below the consensus target of $386.28 and inside a range framed by a 52-week low of $281.00 and a 52-week high of $396.86.
Company
Company: Stryker Corp.
ISIN: US8636671013
Ticker: SYK
Exchange: NYSE
Price (as of August 25, 2026): $327.80 USD
Market cap: $126.37 billion
Sector / Industry: Health Care / Medical Devices
Index membership: S&P 500
